ChemoCentryx Receives European Priority Medicines Designation for ANCA-Associated Vasculitis Treatment CCX168 … – Sonoran Weekly Review

ChemoCentryx Receives European Priority Medicines Designation for ANCA-Associated Vasculitis Treatment CCX168 … – Sonoran Weekly Review

ChemoCentryx Receives European Priority Medicines Designation for ANCA-Associated Vasculitis Treatment CCX168 … – Sonoran Weekly Review
Published on 2016-06-01